We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/4/2020 17:14 | This is a long term hold. Not going to be news every week /month. trials are set to start later in the year results next year. Unless drugs in the pipeline are partnered off. But if you can wait the upside potential is enormous imho. | leedslad001 | |
18/4/2020 16:13 | Does not put people off in Avct Ncyt and Sng OAP the ramps on those threads are off the scale. Started the week at 22p bid online finished at 23p bid...bit deflating really. Weird the nasdaq price dipped quite a bit but still finished over 20% up on the week where we did 5% on bid and 10% on the offer | dave4545 | |
18/4/2020 16:09 | Hope it doesn't degenerate to a P&D board. Might put a lot of people off investing here. The potential is already clear in the RNS releases. Just need one successful trial and move to orders and it will ramp itself.Topped up earlier so sitting and waiting.Good luck | oapknob1 | |
18/4/2020 10:39 | Leeds lad. Good job we didn't have a big surge as there would be plenty of DH's here. It sells itself imo so your are right, pump and dump merchants are not welcome. | showmethemoneyhoney01 | |
18/4/2020 10:00 | Master RSI. I thought there might have been a leak of development news but understand that article will have added a bit of interest. MPH are making great progress on a number of rare disease projects and if only one gets to commercialization and the market cap will be worth many multiples. For this reason I hope they are not tempted by offers from larger Pharma's unless it is considerable at this stage. With high levels of institutional ownership, I think they would rather hold out so see how these projects mature. Added a few more this week to hold mostly in my SIPP and with just over 100,000 shares, they could make a notable difference to my pension pot if these advanced stage projects get approval and are commercialised. | showmethemoneyhoney01 | |
17/4/2020 22:13 | showmethemoneyhoney0 The large move was due to the report... Gilead in talks about buying stake in TIGIT biotech Arcus- Apr 16, 2020 But pharma shares are very hot at the moment and certainly, the company is well undervalued even at the current price. "Companies that want to buy their way into the TIGIT field have a few options, including Arcus. Other companies with anti-TIGIT drugs in their pipelines include iTeos Therapeutics and Mereo BioPharma. Shares in Mereo rose 25% in early trading in London following the report of Gilead’s interest in Arcus. And iTeos is a privately held company that raised $125 million at the start of the month. " | master rsi | |
17/4/2020 21:56 | This is news led. Thought there might have been a leak. Maybe not but nothing has changed. Great potential imo. | showmethemoneyhoney01 | |
17/4/2020 13:59 | Has to be a sell order in | leedslad001 | |
17/4/2020 12:58 | currently the spread is 1.56 v 1.60 and plenty of deals being done already edit - closing spread 1.34 v 1.45 | master rsi | |
17/4/2020 11:34 | 1.55 @ pre market | leedslad001 | |
17/4/2020 09:52 | Been wide spread all day but it is hardly encouraging buying or selling. | showmethemoneyhoney01 | |
17/4/2020 09:26 | 2 sellers perhaps - According to last holding rns's - | tomboyb | |
17/4/2020 08:52 | Agree 6-12 month hold for me to see real value not interested trading for 20% gain. | leedslad001 | |
17/4/2020 08:37 | I wonder if market makers in the US are feeding the market here considering the large volumes traded there yesterday, I don't know if it works like that? I'm relaxed. Got a good holding as this will rise considerably on any good news be it a take over or advance of trials. | showmethemoneyhoney01 | |
17/4/2020 08:29 | There must be a seller in the background. | leedslad001 | |
17/4/2020 08:29 | Yup. If it has a nice rise thew expect afternoon shift here | babbler | |
17/4/2020 08:17 | Agree, 24p in US. Let's see what happens today. | showmethemoneyhoney01 | |
17/4/2020 08:08 | Closed at 1.5 but rose a lot higher intra day. See later. | babbler | |
17/4/2020 08:08 | Except it closed at 1.5 | babbler | |
17/4/2020 08:00 | Some early interest in the shares, as the market in general, is UP | master rsi | |
17/4/2020 07:50 | 5 ADS on NASDAQ is worth 1 share in the uk, therefore taking nasdaq close of say $1.5 divide by 5 and say use $1.24 as exchange rate gives equivalent UK share price of 24p, so we are slightly higher than US price at the moment.. | pre |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions